ASCORBATE AND GLUTATHIONE IN CNS INJURY
抗坏血酸和谷胱甘肽在中枢神经系统损伤中的作用
基本信息
- 批准号:6112550
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-06-01 至 1999-05-31
- 项目状态:已结题
- 来源:
- 关键词:age difference antioxidants ascorbate biomarker brain cell cellular pathology cerebral ischemia /hypoxia electrophysiology gender difference glutathione guinea pigs hippocampus histopathology homeostasis laboratory rat neuroprotectants nitric oxide sectioning spreading cortical depression western blottings
项目摘要
Cerebral antioxidants are neuroprotective agents that prevent oxidative
injury during normal aerobic metabolism. Ascorbic acid (ascorbate) and
glutathione (GSH) are the most abundant antioxidants of low molecular
weight in the CNS. At the onset of ischemic injury, energy-dependent
mechanisms that maintain cellular levels of ascorbate and GSH fail, so that
they and other small molecules are lost brain cells. The underlying
premise of this proposal is that loss of intracellular ascorbate and GSH
during ischemia leaves brain cells vulnerable to oxidative damage. Despite
the central role of ascorbate and GSH in the antioxidant network,
surprising little is known about the mechanisms that regulate their
homeostasis in the CNS. The long-term objective of the studies is to
determine the mechanisms that regulate antioxidant homeostasis in the CNS,
which is a necessary first step in the development of appropriate
therapies. Preliminary data indicate ascorbate and GSH levels decrease
with age and vary with gender. These data are consistent with human
epidemiology, which indicate that stroke incidence and severity increase
with age and are greater in males than in females. Proposed studies,
therefore, will necessarily address factors that govern age and sex
differences. Experiments will use HPLC to determine total tissue ascorbate
and GSH, and histological methods to evaluate tissue damage and antioxidant
neuroprotection. In addition, tools are available to monitor the
extracellular levels of ascorbate ([Asc]o). Using voltammetry with carbon
fiber microelectrodes, we will detect [Asc]o in brain slice in vitro and
after middle cerebral artery occlusion (MCAO) in vivo, then combine these
data with total tissue ascorbate content to calculate [Asc]i. Specific
aims are:
1. To determine the differential localization of ascorbate and GSH in the
CNS, with emphasis on the hypothesis that ascorbate is in neurons and GSH
is in glia. We will confirm antioxidant loss in the aging brain and extend
gender studies to include antioxidant enzymes and iron. II. To evaluate
the mechanism of intra-and extracellular ascorbate homeostasis. In vitro
experiments will test the hypothesis that intra- and extracellular
ascorbate concentrations ([Asc]i and [Asc]o) are regulated homeostatically
and that the dynamics of this process change with age. III. To evaluate
where and how ascorbate and GSH protect. In vitro experiments will test
the hypotheses that ascorbate and GSH act intracellularly. IV. To
determine mechanisms of ascorbate and GSH loss in ischemia. We will extend
preliminary data indicating that loss of antioxidants during ischemia is
greater in male rats than in females. V. To determine the relationship
between loss of intracellular ascorbate and in focal ischemia. Experiments
will test the hypothesis that regions with the greatest loss of [Asc]i
during ischemia have the greatest extent of damage.
大脑抗氧化剂是神经保护剂,防止氧化
正常有氧代谢过程中的损伤。 抗坏血酸(抗坏血酸盐)和
谷胱甘肽(GSH)是低分子量的最丰富的抗氧化剂
CNS中的重量。 缺血性损伤开始时,能量依赖性
维持抗坏血酸和GSH细胞水平的机制失败,
它们和其他小分子是丢失的脑细胞。 底层
该建议的前提是细胞内抗坏血酸和GSH的损失
脑缺血会使脑细胞容易受到氧化损伤。 尽管
抗坏血酸和GSH在抗氧化网络中的中心作用,
令人惊讶的是,人们对调节它们的机制知之甚少。
中枢神经系统的稳态。 研究的长期目标是
确定调节CNS中抗氧化剂稳态的机制,
这是发展适当的
治疗 初步数据显示抗坏血酸和谷胱甘肽水平下降
随年龄和性别而变化。 这些数据与人类
流行病学,这表明中风的发病率和严重程度增加,
而在女性中,男性的比例更高。 拟议的研究,
因此,必须解决决定年龄和性别的因素,
差异 实验将使用HPLC测定组织中的总抗坏血酸盐
和GSH,以及组织学方法来评估组织损伤和抗氧化剂
神经保护 此外,还提供了一些工具,
抗坏血酸([Asc]o)的细胞外水平。 使用碳的伏安法
纤维微电极法检测离体脑片中的[Asc]o,
体内大脑中动脉闭塞(MCAO)后,然后将这些联合收割机
用总组织抗坏血酸盐含量的数据计算[Asc]i。 具体
目标是:
1. 为了确定抗坏血酸和GSH的差异定位,
CNS,强调抗坏血酸存在于神经元和GSH中的假设
是在神经胶质细胞中。 我们将证实抗氧化剂的损失,在老化的大脑和延长
性别研究包括抗氧化酶和铁。 二. 评价
细胞内外抗坏血酸平衡的机制。 体外
实验将检验细胞内和细胞外
抗坏血酸浓度([Asc]i和[Asc]o)受到稳态调节
这个过程的动力学随着年龄的增长而变化。 三. 评价
抗坏血酸和谷胱甘肽在哪里以及如何保护。 体外实验将测试
抗坏血酸和GSH在细胞内起作用的假说。 四. 到
确定缺血时抗坏血酸和GSH损失的机制。 我们将扩展
初步数据表明,缺血期间抗氧化剂的损失是
在雄性大鼠中高于雌性大鼠。 五、确定关系
细胞内抗坏血酸的损失和局部缺血之间的关系。 实验
将检验假设,即[Asc]损失最大的区域是
在局部缺血时损伤程度最大。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Margaret E Rice其他文献
Margaret E Rice的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Margaret E Rice', 18)}}的其他基金
Dopamine Release Regulation by Co-Released Glutamate and GABA
谷氨酸和 GABA 共同释放的多巴胺释放调节
- 批准号:
9031754 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Afterhyperpolarization in dopamine neurons, H2O2 and KATP channels
多巴胺神经元、H2O2 和 KATP 通道的后超极化
- 批准号:
7921292 - 财政年份:2008
- 资助金额:
-- - 项目类别:
Electrochemical Analysis of Dendritic Dopamine Release
树突状多巴胺释放的电化学分析
- 批准号:
6740204 - 财政年份:1997
- 资助金额:
-- - 项目类别:
Electrochemical Analysis of Dendritic Dopamine Release
树突状多巴胺释放的电化学分析
- 批准号:
7051463 - 财政年份:1997
- 资助金额:
-- - 项目类别:
相似海外基金
Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
- 批准号:
24K18002 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
- 批准号:
2222215 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
- 批准号:
23K09272 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
- 批准号:
10652764 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
- 批准号:
10730652 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
- 批准号:
22K11609 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
- 批准号:
22K16720 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
- 批准号:
RGPIN-2018-04107 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
- 批准号:
RGPIN-2019-05674 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
- 批准号:
22K12824 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)